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A comparative analysis of fibroblast
growth factor receptor signalling
during Xenopus development
Hannah Brunsdon2 and Harry V. Isaacs1
Department of Biology, University of York, York YO10 5DD, UK
Background Information. The fibroblast growth factor (FGF) signalling system of vertebrates is complex. In common
with other vertebrates, secreted FGF ligands of the amphibian Xenopus signal through a family of four FGF receptor
tyrosine kinases (fgfr1, 2, 3 and 4). A wealth of previous studies has demonstrated important roles for FGF signalling
in regulating gene expression during cell lineage specification in amphibian development. In particular, FGFs have
well-established roles in regulatingmesoderm formation, neural induction and patterning of the anteroposterior axis.
However, relatively little is known regarding the role of individual FGFRs in regulating FGF-dependent processes in
amphibian development. In this study we make use of synthetic drug inducible versions of Xenopus Fgfr1, 2 and
4 (iFgfr1, 2 and 4) to undertake a comparative analysis of their activities in the tissues of the developing embryo.
Results. We find that Xenopus Fgfr1 and 2 have very similar activities. Both Fgfr1 and Fgfr2 are potent activators
of MAP kinase ERK signalling, and when activated in the embryo during gastrula stages regulate similar cohorts
of transcriptional targets. In contrast, Fgfr4 signalling in naı¨ve ectoderm and neuralised ectoderm activates ERK
signalling only weakly compared to Fgfr1/2. Furthermore, our analyses indicate that in Xenopus neural tissue the
Fgfr4 regulated transcriptome is very different from that of Fgfr1.
Conclusion and significance. We conclude that signalling downstream of Fgfr1 and 2 regulates similar processes
in amphibian development. Interestingly, many of the previously identified canonical transcriptional targets of
FGF regulation associated with germ layer specification and patterning are regulated by Fgfr1/Fgfr2 signalling.
In contrast, the downstream consequences of Fgfr4 signalling are different, although roles for Fgfr4 signalling in
lineage specification and anteroposterior patterning are also indicated.

Additional supporting information may be found online in the Supporting Information section at
the end of the article.
Introduction
The vertebrate fibroblast growth factor (FGF) sig-
nalling network is complex. The human genome
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extracellular signal-regulated kinase; ERK, extracellular signal-regulated ki-
nase; FPKM, Fragments Per Kilobase of transcript per Million; Fgf, fibroblast
growth factor; Fgfr, fibroblast growth factor receptor; GO, gene ontology; iFgfr,
inducible; JAK, janus kinase; MAP, mitogen activated protein; MAPK, mitogen
activated protein kinase; MBT, mid-blastula transition; NAM, normal amphib-
ian medium; PLC-γ, phospholipase c gamma; PI3-kinase, Phosphoinositide
3-kinase; PKC, protein kinase c; STAT, signal transducer and activator of tran-
scription protein.
encodes 22 FGF family proteins (Itoh and Ornitz,
2008; Ornitz and Itoh, 2015). FGF1-9 and 19–23
are secreted proteins, and fulfil either paracrine or en-
docrine functions by activating a family of four cell
surface receptor tyrosine kinases (FGFR 1, 2, 3 and
4). Another subgroup of FGFs (FGF11-14) are not
secreted, do not bind to FGFRs and have intracellu-
lar functions (Goldfarb, 2005; Itoh and Ornitz, 2008;
Ornitz and Itoh, 2015).
FGFs mediate a broad range of biological func-
tions during development, including the regulation
of cell growth, survival and differentiation, reviewed
(Bo¨ttcher et al., 2005; Dorey and Amaya, 2010; Pow-
nall and Isaacs, 2010). The specific effects of FGF sig-
nalling are often dependent on developmental stage
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and/or cell-type and understanding the mechanisms
that regulate the diversity and specificity of FGF ac-
tion remains a challenge.
There is evidence for specificity in the downstream
effects resulting from the activation of individual
FGFRs during development (Umbhauer et al., 2000;
Carballada et al., 2001; Yamagishi and Okamoto,
2010). Each of the receptors activate a similar set of
intracellular signal transduction pathways, including
the PLC-γ , PI3-kinase, PKC, JAK/STAT and MAP
kinase pathways, reviewed (Brewer et al., 2016).
However, there is diversity in the degree to which
each pathway is activated by a given FGFR. It has
been reported that FGFR1 activates MAP kinase
ERK more strongly than does FGFR3 and FGFR4.
This has been suggested as a possible mechanism un-
derlying the different responses of PC12 cells to the
activation of FGFR1, 3 and 4 signalling (Raffioni
et al., 1999) and the weakened mitogenic response of
Baf3 cells to FGFR3 or FGFR4 activation compared
to FGFR1 or FGFR2 (Ornitz et al., 1996).
In the present study, we have investigated the
effects of signalling by individual FGFRs in the
amphibian Xenopus. The complement of FGF ligands
and receptors in Xenopus is similar to that of
mammals, with fgfr1, 2, 3 and 4 present, together
with 20 ligands annotated in the Xenopus laevis
genome (Suzuki et al., 2017). Previous studies in
Xenopus have focussed on the role that FGF signalling
plays in regulating gene transcription during germ
layer specification and neural development, reviewed
(Bo¨ttcher et al., 2005; Dorey and Amaya, 2010;
Pownall and Isaacs, 2010). However, relatively little
is currently known about how signalling downstream
of individual FGFRs contributes to the overall FGF
regulatory network in early amphibian development,
particularly during neural development.
We have previously characterised the use of a
drug inducible form of murine FGFR1 (iFGFR1) for
studying FGF signalling in development. iFGFRs
consist of the membrane anchored intracellular
domain from an FGFR protein, fused to the ligand
binding domain of the synthetic dimerisation agent
AP20187 (Figure 1) (Welm et al., 2002; Pownall
et al., 2003b). Analogous to FGF ligand-driven
dimerisation of wild-type FGFRs, addition of the
membrane soluble dimerising agent to cells express-
ing an iFgfr leads to rapid homodimerisation and
activation of downstream signal transduction. Impor-
Figure 1 Schematic diagram of iFgfrs compared to en-
dogenous FGFRs
Panel (A) is a schematic diagram of a wild type FGFR.
FGF ligands bind to extracellular Ig-like domains. Receptor
monomers are drawn into close proximity, and transphospho-
rylation of the kinase domains (red) activate downstream FGF
signalling pathways. Panel (B) shows an iFgfr tethered to the
cell membrane by amyristoylation domain. The 1 µMAP20187
added to culture medium binds to the FKBPv domain, bring-
ing the kinase domains as in (A). The HA tag tethered to the
FKBPv domain enables immunodetection of the construct.
tantly, iFgfrs lack their extracellular ligand binding
domains, and are not activated by endogenous FGF
ligands. Thus, iFgfrs are a means to analyse the ef-
fects resulting from specifically activating signalling
downstream of each FGFR, in the absence of the com-
plexities that result from the promiscuous receptor
binding properties of individual FGF ligands.
In the present study, we have developed drug
inducible forms of Xenopus FGF receptors 1, 2
and 4 (iFgfr1, 2 and 4) to determine whether the
different Fgfrs mediate distinct biological activities
after mesoderm induction, and during gastrula
stages. Using iFgfr constructs expressed in Xenopus
embryonic tissues, we show that iFgfr1 and iFgfr2
both strongly activate MAP kinase ERK, whereas
iFgfr4 is a relatively weak activator. Similarly,
we find that iFgfr1 and iFgfr2 regulate similar
patterns of gene expression in whole embryos during
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gastrula stages. In contrast, we find that iFgfr1 and
iFgfr4 signalling in neuralised tissue explants elicits
distinct patterns of gene expression. We conclude
that Fgfr1 and Fgfr2 mediate a common set of
processes during early amphibian development, and
these are distinct from those mediated by Fgfr4.
Results and discussion
iFgfrs have differing abilities to activate MAP
kinase ERK
The present study was aimed at investigating FGFR
gene regulatory pathways during gastrula stages. An
analysis of temporal expression profiles of Xenopus
laevis Fgfrs based on published RNA-Seq data (Ses-
sion et al., 2016), indicates that expression levels of
fgfr1, 2 and 4 are elevated from late blastula stages
through to the end of gastrulation. However, fgfr3
shows low-level maternal expression, which declines
at the start of gastrulation and only begins to rise
again at the early neurula stage (Supporting Inforam-
tion Figure 1). As a result, we have not included fgfr3
in our study.
Treatment of blastula stage animal hemisphere ex-
plants (henceforth animal cap explants) with several
different FGF ligands induces mesodermal cell fate
in this pluripotent cell population (Slack et al., 1987;
Isaacs et al., 1992; Song and Slack, 1996; Lombardo
et al., 1998; Fletcher et al., 2006), accompanied
by activation of MAP kinase signalling (LaBonne
et al., 1995; Christen and Slack, 1999b). We used
animal cap explants to investigate the ability of each
iFgfr to activate MAP kinase signalling. Western
blotting shows that the induction of signalling by
addition of the dimerising agent AP20187 to iFgfr1,
2 and 4 injected animal cap explants increased levels
of activated diphospho-ERK (dp-ERK) relative to
uninduced control explants (Figure 2A). The most
robust increases occurred with iFgfr1 and 2, with
only a modest upregulation resulting from iFgfr4
activation. We note that the strong phosphorylation
of ERK following activation of iFgfr1 and 2 repro-
ducibly led to a concomitant reduction in the level
of total ERK detected. The less potent activation
of ERK by iFgfr4 did not have this effect. It is not
clear whether this is genuine downregulation of total
ERK levels or represents a masking of the total ERK
epitope in the phosphorylated form of the protein.
Immunohistochemical analysis of the spatial dis-
tribution dp-ERK reactivity in control uninjected
embryos shows that ERK activation is restricted to
known areas of endogenous FGF signalling in the
equatorial region of the embryo (Figure 2B). In keep-
ing with previous studies dp-ERK immunoreactivity
is not detected in animal hemisphere cells (see control
uninjected and iFgfr injected embryos in Figure 2C)
(Christen and Slack, 1999b; Branney et al., 2009).
In contrast, Figure 2C shows ectopic dp-ERK
staining in the animal hemisphere after animal hemi-
sphere injections of iFgfr constructs and subsequent
activation with AP20187 for 2 h. Activation of iFgfr1
and iFgfr2 resulted in robust and widespread dp-ERK
immunostaining, whereas induction of iFgfr4 sig-
nalling led to weaker and less widespread dp-ERK ac-
tivation. We conclude that Fgfr4 is a weak activator of
MAP kinase signalling compared to both Fgfr1 and 2.
Signalling by different iFgfrs has distinct effects
on tissue morphogenesis
Animal cap explants treated with mesoderm-
inducing FGF ligands elongate during gastrula and
neurula stages, as the induced tissues undergo cell
movements mimicking the morphogenetic move-
ments of the mesoderm during normal development
(Slack et al., 1988). Figure 3A shows that activation
of iFgfr1 and iFgfr2 signalling induced tissue explant
elongation, whereas iFgfr4 signalling did not.
Injection of synthetic FGF mRNAs into zygotes
causes the rapid accumulation of FGF protein
during cleavage and blastula stages, and results
in catastrophic disruption of development due to
the induction of ectopic mesodermal tissues during
mid- to late-blastula stages (Isaacs et al., 1994).
To investigate the effects of FGF overexpression in
post-blastula stages plasmid-based, promoter driven
expression of FGF ligands has been used in number
of studies (Isaacs et al., 1994; Pownall et al., 1996).
This methodology restricts ectopic FGF expression
until after activation of zygotic transcription at
the mid-blastula transition (MBT). Post-MBT FGF
overexpression results in a penetrant posteriorised
phenotype, characterised by loss of anterior struc-
tures, including eyes and anterior neural domains
(Isaacs et al., 1994; Pownall et al., 1996).
Here we have investigated the effects on larval
phenotype when signalling by different iFgfrs is acti-
vated only from early gastrula stages onwards. ifgfr1,
2 and 4 were injected into Xenopus laevis embryos and
AP20187 added at gastrula stage 10.5. Figure 3B
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Figure 2 Effects of iFgfr activation on MAP kinase signalling
(A) Western blot showing levels of diphospho-ERK (dpERK) and total ERK in animal cap explants from embryos injected with
20 pg iFgfr1, iFgfr2 or iFgfr4 mRNA. Explants were removed at blastula stage 8 and treated with AP20187 for 2 h. (B) Whole
mount immunohistochemical detection (vegetal view) of dpERK in the marginal zone of a gastrula stage 10 control embryo. (C)
Whole mount immunohistochemical detection (animal view) of dpERK in animal hemisphere cells of gastrula stage 10 control
embryos and embryos injected with 20pg iFgfr1, iFgfr2 or iFgfr4 mRNA (plus or minus 1 µM AP20187 treatment from blastula
stage 8). Percentages of explants from a representative experiment exhibiting the presented phenotype are indicated.
shows that uninjected control embryos, and those
injected with ifgfrs but not treated with AP20187,
developed normally. However, activation of iFgfr1 or
iFgfr2 signalling caused severe defects, with reduced
head development, including loss of eyes, cement
gland and defective anteroposterior elongation
relative to controls. These phenotypes are similar to
those reported to arise from post-MBT activation of
FGF4 signalling (Isaacs et al., 1994; Pownall et al.,
1996). iFgfr4 activation produced penetrant, but
milder defects than either iFgfr1 or iFgfr2 activation.
Eyes were typically underdeveloped and this was
accompanied by failure to properly elongate along
the anteroposterior axis. Unlike with iFgfr1 and
iFgfr2 activation, in iFgfr4-activated embryos the
cement gland was not typically lost and was some-
times enlarged. We conclude that ectopic activation
of Fgfr1 and Fgfr2 signalling has similar effects on
morphogenesis of the Xenopus embryo, which are
distinct from those resulting from Fgfr4 signalling.
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Figure 3 Effects of iFgfr activation on tissue morphogenesis
Panel (A) compares the appearance of animal caps from embryos injectedwith 20pg ifgfr1, ifgfr2 or ifgfr4mRNA± 1 µMAP20187.
AP20187 treatments occurred from blastula stage 8 until late neurula stage 18. Percentages of explants from a representative
experiment exhibiting the presented phenotype are indicated, ifgfr1, n = 9, ifgfr2 n = 12, ifgfr4, n = 11. Panel (B) compares
the appearance at the tailbud stage of embryos injected with 20pg ifgfr1, ifgfr2 or ifgfr4 mRNA (±1 µM AP20187). AP20187
treatment was continuous from gastrula stage 10.5. Percentages of embryos from a representative experiment exhibiting the
presented phenotype are indicated, iFgfr1, n = 20, iFgfr2 n = 15, iFgfr4, n = 20.
Signalling by iFgfr1 and iFgfr2 regulates similar
patterns of gene expression in gastrula stage
embryos
Our data indicate that Fgfr1 and Fgfr2 have
similar abilities to activate MAP kinase ERK, and
ectopic signalling by either receptor results in
rather similar phenotypic effects on development.
We were interested to see if iFgfr1 and iFgfr2
signalling also results in similar effects on the
early embryo transcriptome. Using the Affymetrix
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microarray platform, we investigated changes in the
transcriptome of embryos in which iFgfr1 and iFgfr2
signalling was activated from early gastrula stage
10.5 through to late gastrula stage 13.
Our expression analysis used sibling groups of con-
trol, iFgfr1 and iFgfr2-injected embryos. We adopted
a strict filtering criterion of discarding data points
if expression values of <50 FPKM were detected in
both groups being compared (raw and filtered data
sets are available in Supporting Information Spread-
sheet 1). Scatterplots comparing log2 gene expression
from these analyses are shown in Figure 4. Figure 4A
is an analysis of expression levels in uninjected control
embryos cultured either with or without AP20187.
Of 10,958 probe sets passing the expression cut-off,
we found that only six probe sets changed by more
than or equal to twofold (4 up and 2 down) when
AP20187 is added. This indicates culture in the
presence of AP20187 had little effect on gene expres-
sion and, furthermore, at the expression cut-off levels
employed, there was a high degree of congruence
in gene expression between control groups. The
high reproducibility between control groups is again
demonstrated in Figure 4B, which compares gene
expression in uninduced iFgfr1 and iFgfr2 groups.
Of 10,794 genes passing the expression cut-off,
only five probe sets differ by more than or equal to
twofold (2 up and 3 down) between the two groups.
In contrast to the control groups, using 50 FPKM
expression level cut-off, and more than or equal to
twofold change criteria, we found that iFgfr1 and
iFgfr2 activation resulted in differential expression
of a number of genes. iFgfr1 activation upregulated
45 probe sets (Supporting Information Table 1) and
downregulated 149 probe sets (Supporting Informa-
tion Table 2). iFgfr2 activation upregulated 39 probe
sets (Supporting Information Table 3) and downregu-
lated 46 probe sets (Supporting Information Table 4).
The overlap between up and downregulated probe
sets of uninduced versus induced iFgfr1 and iFgfr2
groups was investigated and is summarised in Sup-
porting Information Spreadsheet 2 and the Venn dia-
gram in Figure 4D. Whilst there are qualitative and
quantitative differences in the effects of iFgfr1 and
iFgfr2 activation on gene expression, it is striking
that there are large overlaps between the regulated
gene cohorts. Thus, of the 45 probe sets upregulated
by iFgfr1, 56% were also upregulated by iFgfr2, and
of the 39 probe sets upregulated by iFgfr2, 64%
were also upregulated by iFgfr1. Similarly, of the 149
probe sets downregulated by iFgfr1, 27% were also
downregulated by iFgfr2, and of the 46 probe sets
downregulated by iFgfr2, 87% were also downregu-
lated by iFgfr1. Overall, our data support the notion
that Fgfr1 and Fgfr2 regulate the expression of very
similar cohorts of genes and this correlates with the
similar effects resulting from their activation during
gastrulation.
Previous transcriptomic studies of FGF signalling
have involved inhibition or activation of FGF
signalling from earlier blastula stages. Our study is
designed to activate FGF signalling during a later
time window towards the end of gastrulation, so we
therefore expected to identify a cohort of FGF targets
specifically regulated during this period. In addition
to egr1, cdx1, msx2, wnt8a and spry2, which have
been identified as being positively regulated by FGF
signalling in previous Xenopus studies, we found both
the nodal antagonist gene lefty and the nek6 kinase
gene to be upregulated by iFgfr1 and iFgfr2 which
represent novel targets of FGF regulation at this later
stage (Supporting Information Tables 1 and 3). In
keeping with this, T/brachyury and myod, which are
typically highly activated at the late blastula stage
in the mesoderm, were only upregulated by 1.5- and
1.2-fold, respectively, in this data, and thus do not
pass our strict selection criteria.
iFgfr1 and iFgfr4 signalling affects neural
development
Previous studies have indicated that Fgfr1 and Fgfr4
signalling have differing effects on Xenopus neural
development (Hongo et al., 1999; Hardcastle et al.,
2000; Umbhauer et al., 2000). We investigated the
effects of iFgfr1 and 4 signalling on neural develop-
ment by targeted mRNA injection at the eight-cell
stage into the two dorsal animal blastomeres, which
are fated to make extensive contribution to the ner-
vous system (Dale and Slack, 1987). iFgfr signalling
was activated from gastrula stage 10.5 and pheno-
typic effects observed at larval stages. Figure 5A
shows that activating iFgfrs in prospective neural
tissue had less severe effects than when iFgfrs are
expressed globally (Figure 3B). However, activation
of either receptor caused defects in eye development.
Activation of iFgfr1 signalling resulted in reduced
retinal pigmentation and eye size, sometimes with
the lens absent. In iFgfr4-induced embryos, the most
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Figure 4 See Legend on next page
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Figure 4 Effects of iFgfr1 and iFgfr2 activation on the transcriptome of gastrula stage embryos
Scatterplots of log2 gene expression levels in late gastrula stage 13 embryos were generated using the Affymetrix microarray
platform. Data were filtered with a cut-off to exclude array features with expression levels <50. Data points in the white zone
proximal to the black line (y = x) have less than twofold change in expression. Data points in the green zone have more than
twofold increase in expression relative to control (x-axis). Data points in the red zone indicate more than twofold decrease
in expression relative to control. Panel (A) compares gene expression in control uninjected embryos and uninjected embryos
treated with 1 µM AP20187 from early gastrula stage 10.5. Panel (B) compares gene expression in embryos injected with 20pg
ifgfr1 or ifgfr2 mRNA in the absence of AP20187 treatment (uninduced). Panels (C) and (D) compare gene expression in embryos
injected with either 20pg iFgfr1 (C) or iFgfr2 mRNA (D) cultured in the absence (uninduced) or presence of 1 µM AP20187 from
stage 10.5 (induced). Panel (E) is a Venn diagram showing the overlap of the gene sets up- and downregulated by more than or
equal to twofold following activation of iFgfr1 and iFgfr2 signalling during gastrula stages.
common effect was missing pigmentation in parts of
the retina. Previously, FGF signalling has been linked
to eye development and regeneration in Xenopus and
both fgfr1 and fgfr4 are expressed in the larval eye
(Fukui and Henry, 2011; Kim et al., 2015). Dereg-
ulation of normal FGF signalling in the developing
eye after iFgfr activation likely underpins the ob-
served eye development defects observed in the cur-
rent study.
iFgfr1 and iFgfr4 signalling activates MAP kinase
signalling in neuralised ectoderm
To investigate the differing roles of Fgfr1 and Fgfr4
in regulating gene transcription during neural devel-
opment we utilised the ability of the BMP inhibitor
Noggin to neuralise animal caps explants, in combi-
nation with activation of iFgfr signalling. Our assay
consisted of co-injecting noggin and ifgfr mRNAs
into the early embryo. Animal caps were explanted
at mid-blastula stage 8 and cultured until stage-
matched control embryos reached early gastrula stage
10.5, at which point iFgfr signalling was induced for
3 h. Figure 5B is a western blot demonstrating that
injection of noggin mRNA massively downregulated
levels of phosphoSmad1/5/8 (pSmad1,5,8) (lane 3)
compared to control animal caps (lane 4), indicating
the effective inhibition of BMP signalling in animal
cap explants, and this inhibition was not affected
when iFgfr signalling was activated at the early
gastrula stage (lane 7). Furthermore, the inhibition
of BMP signalling did not compromise the ability of
iFgfr signalling to activate MAP kinase signalling,
as shown by levels of dp-ERK in non-neuralised
animal caps (lane 5) versus neuralised animal caps
(lane 7). Figure 5C shows that iFgfr4 signalling also
upregulated dp-ERK levels, although, as previously
shown (Figure 2) the activation of MAP kinase
signalling was less potent than seen with iFgfr1.
iFgfr1 and iFgfr4 signalling activates different
patterns of gene expression in neuralised
ectoderm
We used RNA-seq analysis to compare gene expres-
sion in Noggin-neuralised ectodermal explants and
neuralised explants in which iFgfr1 or iFgfr4 sig-
nalling was induced at gastrula stage 10.5 for 3 hours.
The rationale for using a short period of induction
was to focus the analysis on proximal transcriptional
events following activation of FGFR signalling.
Animal cap explants from a sibling group of control,
ifgfr1 and ifgfr4 injected embryos were analysed.
Supporting Information Figure 2 shows a scatterplot
comparing log2 unfiltered FPKM values for each
annotated transcript model in uninduced iFgfr1 and
iFgfr4 animal caps. There was considerable random
variation in expression at the lower end of the
dynamic range in this experiment. Therefore, a strict
expression filter exclusion of<30 FPKM was adopted
(raw and filtered data sets are available in Supporting
Information Spreadsheet 3). Figure 6A shows that in
the absence of AP20187, gene expression in ifgfr1
and ifgfr4 injected animal caps is very similar. A
total of 6482 annotated transcripts were identified
as passing the 30 expression cut-off criterion,
and of these only five (1 up and 4 down) exhibited
more than or equal to twofold change in expression.
In contrast, a considerable number of transcripts
were up and downregulated by induction of iFgfr
signalling following the addition of AP20187.
A comparison between the iFgfr1 and iFgfr4 up
and down regulated transcriptomes (Supplementary
Tables 5, 6,7 and 8) contrasts with our analysis
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Figure 5 Effects of iFgfr1 and iFgfr4 activation in neural tissue
Panel (A) compares the appearance of control uninjected tailbud stage embryos and embryos injected into the two dorso-animal
blastomeres at the eight-cell stage with 20 pg ifgfr1 or ifgfr4 mRNA cultured in the absence (uninduced) or presence of 1 µM
AP20187 from stage 10.5 (induced). Higher magnification images of disrupted eye development are shown inset. Black arrow
indicates missing lens. White arrow indicates disrupted pigmentation in the retina. (B) Western blot showing levels of phospho-
Smad1, 5, 8 (pSmad1/5/8), diphospho-ERK (dpERK) and total ERK animal cap explants at early neurula stage 15. Explants were
taken from control uninjected embryos and embryos injected with 20 pg ifgfr1 mRNA or 50 pg noggin mRNA or coinjected with
20 pg ifgfr1 mRNA and 50 pg noggin mRNA. Explants from embryos injected with ifgfr1 were cultured in the absence (uninduced)
or presence of 1 µM AP20187 from stage 10.5 (induced). (C) Western blot analysing levels of diphospho-ERK (dpERK) and total
ERK levels animal cap explants from embryos injected with 20 pg ifgfr1 mRNA or ifgfr4 mRNA. Explants were cultured in the
absence (uninduced) or presence of 1 µM AP20187 from stage 10.5 (induced) for 3 h.
of iFgfr1 versus iFgfr2 regulated transcriptomes
(Figures 4D and 6D). After the multiple transcripts
models available for each gene were consolidated
to single annotated genes, 125 and 188 genes were
called as being upregulated by iFgfr1 and iFgfr4
signalling respectively. Only 5 genes were present
in the overlap between both groups. Similarly, there
was an overlap of only 10 genes between the 78 genes
downregulated by iFgfr1 and 96 downregulated by
iFgfr4. 6 genes were also regulated in opposite direc-
tions by iFgfr1 and iFgfr4 activation (Summarised
in Supporting Information Spreadsheet 4).
Gene ontology (GO) analysis of up- and
downregulated genes using the slim molecular
function terms in PANTHER Classification System
(www.pantherdb.org) indicates that genes upreg-
ulated by iFgfr1 signalling were enriched 15.3×
above expected values for MAP kinase-related genes
(FDR= 1.3× 10−02). So for example, the previously
identified FGF targets and feedback inhibitors of
MAP kinase signalling spry1, dusp1 and dusp5 were
upregulated by iFgfr1 signalling in this study
(Sivak et al., 2005; Branney et al., 2009). Genes
downregulated by iFgfr1 were enriched for the
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Figure 6 Effects of iFgfr1 and iFgfr4 activation on the transcriptome of neuralised tissue explants
Scatterplots of log2 expression gene expression levels in neuralised animal cap explants generated from RNA-seq analysis data.
Data were filtered with a cut-off to exclude identified gene models with expression levels <30 (FKPM). Data points in the white
zone, proximal to the black line (y = x) have less than twofold change in expression. Data points in the green zone have a more
than twofold increase in expression relative to control (x-axis). Data points in the red zone indicate more than twofold decrease
in expression relative to control. Panel (A) compares gene expression in explants from embryos injected with 20 pg ifgfr1 or
ifgfr4 mRNA in the absence of AP20187 treatment (uninduced). Panels (B) and (C) compare gene expression in explants from
embryos injected with 20 pg ifgfr1 (B) or ifgfr4 mRNA (C) cultured in the absence (uninduced) or presence of 1 µM AP20187
from stage 10.5 for 3 h (induced). Panel (D) is a Venn diagram showing the overlap of gene sets up and down regulated by more
than or equal to twofold following activation of iFgfr1 and iFgfr4 signalling in neuralised animal caps explants.
molecular function RNA binding (6.09x enrichment
and 9.74×10−04). In contrast, the cohorts of genes
up and down regulated by iFgfr4 signalling showed
no significant enrichment in slim molecular function
terms using the same analysis.
It has been proposed that Xenopus Fgfr4 signalling
is more strongly involved in neural development than
Fgfr1 (Hongo et al., 1999; Hardcastle et al., 2000;
Umbhauer et al., 2000). However, our analysis does
not indicate enrichment of genes involved in neural
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development regulated by Fgfr4 signalling. In fact,
we found that many genes associated with neural
development, including the transcription factor
genes foxd4l1, hes1, foxb1, oct25, oct91 and sp5l were
upregulated by iFgfr1, rather than iFgfr4 signalling
(Supplementary Spreadsheet 4). Despite this obser-
vation, there are indications that Fgfr4 signalling
is involved in cell lineage specification as we found
that epidermal markers krt5.7, tuba1a and xepsin
were strongly downregulated by Fgfr4 signalling.
A role for Fgfr4 signalling in axial patterning was
also indicated, as the anterior marker genes hesx1,
rax and otx2 are strongly downregulated by iFgfr4
activation. This indicates that Fgfr4 signalling likely
contributes to the recognised role of FGF signalling
in suppressing anterior and promoting posterior
development (Cox Wm and Hemmati-Brivanlou,
1995; Lamb and Harland, 1995; Pownall et al.,
1996; Polevoy et al., 2019).
Conclusion
We conclude that the use of timed activation of sig-
nalling by individual iFgfrs in whole embryos and
within a specific tissue, neural in this case, provides a
powerful tool for dissecting the role of FGF signalling
in amphibian development. Our data show that Fgfr1
and Fgfr2 signalling have similar biological effects in
the tissues of the early Xenopus embryo. We specu-
late that this is underpinned by the ability of both
Fgfr1 and 2 to robustly stimulate MAP kinase sig-
nalling. In contrast, Fgfr4 only weakly activates MAP
kinase signalling and has roles distinct from Fgfr1 in
regulating gene expression in developing amphibian
neural tissue.
Materials and methods
iFgfr constructs
The CS2+murine iFgfr1 plasmid was PCR modified to remove
the murine FGFR1 kinase domain sequence, generating a Nhe1
restriction site downstream of the myristolation sequence and
an Mlu1 restriction site upstream of the sequence encoding the
two AP20187 binding dimerisation domains. Sequences coding
for the C-termini of Xenopus laevis fgfr1, 2,3 and 4 (accession
number BC025936, BC073456, BC073428 and BC033318, re-
spectively) were PCR amplified. In all cases the sequence am-
plified encoded the whole intracellular domain beginning four
amino acids after the end of the transmembrane domain. Dur-
ing PCR amplification, 5’ Nhe1 and 3’ Mlu1 restriction sites
were generated in each fragment. After restriction enzyme di-
gest the kinase domain sequences were cloned in frame into the
Nhe1/Mlu1 site of the modified pCS+ vector. Each iFgfr pro-
tein was also tagged with a HA-epitope to allow monitoring of
protein translation efficiency. Synthetic iFgfr mRNAs were pro-
duced from Not1 linearised templates by in vitro transcription
using the SP6 Megascript kit (Ambion) and a modified protocol
using a 1:10 ratio of GTP to m7G(5’)Gppp(5’)G cap.
Embryological methods
Preliminary experiments (data not shown) were undertaken to
determine optimal amounts of iFgfr mRNAs to inject and con-
centration of dimerising drug AP20187 to apply to injected
tissues. Using Xenopus laevis embryos, we concluded that 20pg
iFgfr mRNA minimised drug independent activation of FGFR
signalling and exposure of tissues to 1 µM AP20187 elevates
the levels of activated diphospho-ERK (dp-ERK) in less than 15
min. This is in keeping with results obtained using an inducible
murine FGFR1 (Pownall et al., 2003a). Embryos were injected
with iFgfr mRNAs at the two-cell stage. For whole embryo ex-
periments, Xenopus laevis embryos were cultured until stage 10.5
in NAM/3 +5% Ficoll and the treated with 1 µM AP20187
[Clontech] in NAM/10 until late gastrula/early neurula stage
13. For animal cap experiments, embryos were co-injected with
20 pg iFgfr and 50 pg noggin mRNA into the animal pole at
the one- to two-cell stage. Embryos were cultured until Stage 8
before transferring to a solution of NAM/2 and dissecting out
ectodermal explants. Animal caps were cultured in NAM/2 until
stage 10.5 and transferred to a 1 µM solution of AP20187 in
NAM/2 for 3 h. Embryos were staged according to Nieuwkoop
and Faber (Nieuwkoop and Faber, 1967). Embryos were snap
frozen or fixed at the required stage.
Western blotting and immunohistochemistry
Five Xenopus laevis embryos or >10 animal cap explants
were homogenised in 50 µL Phosphosafe (Novogen-Merk).
Samples were analysed by SDS-PAGE and transferred onto
Immobilon Millipore membrane (Fisher Scientific). Membranes
were blocked in 5% milk powder in PBS and incubated
overnight at 4°C in relevant primary antibodies (anti-dp-ERK
(Sigma) 1:8000, anti-phosphoSmad1/5/8 (NEB) 1:500 and
anti-GAPDH (HyTest) 1:1,000,000. Secondary antibodies were
anti-mouse POD (Amersham), 1:3000 and anti-rabbit POD
(Amersham), 1;2000. Signals were visualised with BM Chemilu-
minescence Western Blotting Substrate (POD) (Roche) and ECL
Hyperfilm (Amersham). dp-ERK immunohistochemistry was
carried out according the methods of Christen and Slack (1999).
Transcriptomic analysis
Microarray analysis and RNA-seq analyses were carried on
batches of RNA isolated from sibling embryos or explants from
sibling embryos. Ten embryos or 20 animal caps were extracted
in Tri-reagent (Sigma) according to the manufacturer’s protocol.
RNA for microarray analysis was precipitated using isopropanol
and was further purified using Qiagen RNeasy columns, fol-
lowed by a lithium chloride precipitation. RNeasy purifica-
tion was omitted during the preparation of RNA for RNA-
Seq analysis. Quality of purified total RNA was assessed us-
ing the Agilent 2100 Bioanalyzer. Two micrograms of total
RNA was processed for Affymetrix microarray analysis using the
Affymetrix GeneChip one-cycle target labelling kit (Affymetrix)
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according to the manufacturer’s recommended protocols. Pro-
cessing of microarray samples was as per manufacturer’s instruc-
tions and as previously described (Branney et al., 2009). Scanning
and initial data processing were as previously described (Branney
et al., 2009). Data were imported into BRB ArrayTools software
(http://linus.nci.nih.gov/BRB-ArrayTools.html) for subsequent
analysis.
RNA-seq samples were treated with Ribo-Zero rRNA Re-
moval Kit (Illumina), generated cDNA was fragmented to
100–150 bp and sequenced on an Illumina HiSeq 2500 at
the University of Liverpool Centre for Genomic Research. Ap-
proximately 110 million paired reads were obtained for iFgfr1
Uninduced, 80 million for iFgfr1 Induced, 90 million
for iFgfr4 Uninduced and 85 million reads iFgfr4 Induced.
Raw Fastq files were trimmed for the presence of adapter se-
quences and reads shorter than 10 bp were removed. Mean
read lengths after trimming were 82–96 bp and were aligned
to the Mayball repository of Xenopus laevis longest cDNAs
(http://daudin.icmb.utexas.edu/) using BWA-MEM (http://bio-
bwa.sourceforge.net/; Li & Durbin 2009). Counts of reads per
fragment mapping to each transcript were obtained by using
SAMtools software (http://samtools.sourceforge.net/; Li et al.
2009). Initial analysis identified sequence hits for all models for
individual genes. For subsequent analysis, multiple gene model
hits were consolidated to single entry for each gene passing the
filtering criteria. Threshold adjustment and genelist compiling,
as well as further data analysis were performed in Microsoft
Excel. Venn Diagrams were constructed using a tool on the Uni-
versity of Gent’s Bioinformatics Evolutionary Genomics website
(http://bioinformatics.psb.ugent.be/webtools/Venn/).
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Office project licence P0F245295.
Author contribution
H.B. undertook the experiments in this study and was
involved in figure production and manuscript writ-
ing. H.V.I. conceived the project and was involved in
figure production and manuscript writing.
Acknowledgments
We would like to thank Celina Whalley and Toby
Hodges in the York Biology Technology Facility for
their help with processing of the microarray and
RNA-seq data. H.B. was in receipt of a BBSRC stu-
dentship.
Conflict of interest statement
The authors have declared no conflict of interest.
References
Bo¨ttcher, R.T., Niehrs, C. and Bo, R.T. (2005) Fibroblast growth factor
signaling during early vertebrate development. Endocr. Rev. 26,
63–77
Branney, P.A., Faas, L., Steane, S.E., Pownall, M.E. and Isaacs, H.V.
(2009) Characterisation of the fibroblast growth factor dependent
transcriptome in early development. PLoS One 4, e4951
Brewer, J.R., Mazot, P. and Soriano, P. (2016) Genetic insights into
the mechanisms of Fgf signaling. Genes Dev. 30, 751–771
Carballada, R., Yasuo, H. and Lemaire, P. (2001)
Phosphatidylinositol-3 kinase acts in parallel to the ERK MAP
kinase in the FGF pathway during Xenopus mesoderm induction.
Development 128, 35–44
Christen, B. and Slack, J. (1999a) Spatial response to fibroblast
growth factor signalling in Xenopus embryos. Development 126,
119–125
Christen, B. and Slack, J.M. (1999b) Spatial response to fibroblast
growth factor signalling in Xenopus embryos. Development 126,
119–125
Cox Wm, G. and Hemmati-Brivanlou, A. (1995) Caudalization of
neural fate by tissue recombination and bFGF. Development 121,
4349–4358
Dale, L. and Slack, J.M.W. (1987) Fate map for the 32-cell stage of
Xenopus laevis. Development 99, 527–551
Dorey, K. and Amaya, E. (2010) FGF signalling: diverse roles during
early vertebrate embryogenesis. Development 137, 3731–3742
Fletcher, R.B., Baker, J.C. and Harland, R.M. (2006) FGF8
spliceforms mediate early mesoderm and posterior neural tissue
formation in Xenopus. Development 133, 1703–1714
Fukui, L. and Henry, J.J. (2011) FGF Signaling Is Required for Lens
Regeneration in Xenopus laevis. The Biological Bulletin 221,
137–145
Goldfarb, M. (2005) Fibroblast growth factor homologous factors:
evolution, structure, and function. Cytokine Growth Factor Rev. 16,
215–220
Hardcastle, Z., Chalmers, A.D. and Papalopulu, N. (2000) FGF-8
stimulates neuronal differentiation through FGFR-4a and interferes
with mesoderm induction in Xenopus embryos. Curr. Biol. 10,
1511–1514
Hongo, I., Kengaku, M. and Okamoto, H. (1999) FGF signaling and
the anterior neural induction in Xenopus. Dev Biol 216, 561–581
Isaacs, H.V., Pownall, M.E. and Slack, J.M. (1994) eFGF regulates
Xbra expression during Xenopus gastrulation. EMBO J. 13,
4469–4481
Isaacs, H.V., Tannahill, D. and Slack, J.M.W. (1992) Expression of a
novel FGF in the Xenopus embryo. A new candidate inducing
factor for mesoderm formation and anteroposterior specification.
Development 114, 711–720
Itoh, N. and Ornitz, D.M. (2008) Functional evolutionary history of the
mouse Fgf gene family. Dev Dyn. 237, 18–27
Kim, Y.J., Bahn, M., Kim, Y.H., Shin, J.Y., Cheong, S.W., Ju, B.G.,
Kim, W.S. and Yeo, C.Y. (2015) Xenopus laevis FGF receptor
substrate 3 (XFrs3) is important for eye development and mediates
Pax6 expression in lens placode through its Shp2-binding sites.
Dev. Biol. 397, 129–139
LaBonne, C., Burke, B. and Whitman, M. (1995) Role of MAP kinase
in mesoderm induction and axial patterning during Xenopus
development. Development 121, 1475–1486
Lamb, T.M. and Harland, R.M. (1995) Fibroblast growth factor is a
direct neural inducer, which combined with noggin generates
anterior-posterior neural pattern. Development 121, 3627–3636
Li, H. and Durbin, R. (2009) Fast and accurate short read alignment
with Burrows-Wheeler Transform. Bioinformatics 25, 1754–1760
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N.,
Marth, G., Abecasis, G. and Durbin, R. (2009) The Sequence
12 www.biolcell.net | Volume (112) | Pages 1–13
A comparative analysis of fibroblast growth factor Research article
Alignment/Map format and SAMtools. Bioinformatics 25,
2078–2079
Lombardo, A., Isaacs, H.V. and Slack, J.M. (1998) Expression and
functions of FGF-3 in Xenopus development. Int. J. Dev. Biol. 42,
1101–1107
Nieuwkoop, P.D. and Faber, J. (1967) Normal Table of Xenopus laevis
(Daudin). Garland, Amsterdam
Ornitz, D.M. and Itoh, N. (2015) The Fibroblast Growth Factor
signaling pathway. Wiley Interdiscip. Rev. Dev. Biol. 4, 215–266
Ornitz, D.M., Xu, J., Colvin, J.S., McEwen, D.G., MacArthur, C.A.,
Coulier, F., Gao, G. and Goldfarb, M. (1996) Receptor specificity of
the fibroblast growth factor family. J. Biol. Chem. 271,
15292–15297
Polevoy, H., Gutkovich, Y.E., Michaelov, A., Volovik, Y., Elkouby, Y.M.
and Frank, D. (2019) New roles for Wnt and BMP signaling in
neural anteroposterior patterning. EMBO Rep. 20, 1–13
Pownall, M.E. and Isaacs, H.V. (2010) FGF Signalling in Vertebrate
Development. Biota, Princeton, NJ
Pownall, M.E., Tucker, A.S., Slack, J.M.W. and Isaacs, H.V. (1996)
eFGF, Xcad3 and Hox genes form a molecular pathway that
establishes the anteroposterior axis in Xenopus. Development 122,
3881–3892
Pownall, M.E., Welm, B.E., Freeman, K.W., Spencer, D.M., Rosen,
J.M. and Isaacs, H.V. (2003a) An inducible system for the study of
FGF signalling in early amphibian development. Dev. Biol. 256,
89–99
Pownall, M.E., Welm, B.E., Freeman, K.W., Spencer, D.M., Rosen,
J.M. and Isaacs, H.V. (2003b) An inducible system for the study of
FGF signalling in early amphibian development. Dev. Biol. 256,
89–99
Raffioni, S., Thomas, D., Foehr, E.D., Thompson, L.M. and
Bradshaw, R.A. (1999) Comparison of the intracellular signaling
responses by three chimeric fibroblast growth factor receptors in
PC12 cells. Proc. Natl. Acad. Sci. U. S. A. 96, 7178–7183
Session, A.M., Uno, Y., Kwon, T., Chapman, J.A., Toyoda, A.,
Takahashi, S., Fukui, A., Hikosaka, A., Suzuki, A., Kondo, M., van
Heeringen, S.J., Quigley, I., Heinz, S., Ogino, H., Ochi, H., Hellsten,
U., Lyons, J.B., Simakov, O., Putnam, N., Stites, J., Kuroki, Y.,
Tanaka, T., Michiue, T., Watanabe, M., Bogdanovic, O., Lister, R.,
Georgiou, G., Paranjpe, S.S., van Kruijsbergen, I., Shu, S., Carlson,
J., Kinoshita, T., Ohta, Y., Mawaribuchi, S., Jenkins, J., Grimwood,
J., Schmutz, J., Mitros, T., Mozaffari, S.V., Suzuki, Y., Haramoto, Y.,
Yamamoto, T.S., Takagi, C., Heald, R., Miller, K., Haudenschild, C.,
Kitzman, J., Nakayama, T., Izutsu, Y., Robert, J., Fortriede, J.,
Burns, K., Lotay, V., Karimi, K., Yasuoka, Y., Dichmann, D.S.,
Flajnik, M.F., Houston, D.W., Shendure, J., DuPasquier, L., Vize,
P.D., Zorn, A.M., Ito, M., Marcotte, E.M., Wallingford, J.B., Ito, Y.,
Asashima, M., Ueno, N., Matsuda, Y., Veenstra, G.J., Fujiyama, A.,
Harland, R.M., Taira, M. and Rokhsar, D.S. (2016) Genome
evolution in the allotetraploid frog Xenopus laevis. Nature 538,
336–343
Sivak, J.M., Petersen, L.F. and Amaya, E. (2005) FGF signal
interpretation is directed by Sprouty and Spred proteins during
mesoderm formation. Dev. Cell 8, 689–701
Slack, J.M., Darlington, B.G., Heath, J.K. and Godsave, S.F. (1987)
Mesoderm induction in early Xenopus embryos by heparin-binding
growth factors. Nature 326, 197–200
Slack, J.M.W., Isaacs, H.V. and Darlington, B.G. (1988) Inductive
effects of fibroblast growth factor and lithium ion on Xenopus
blastula ectoderm. Development 103, 581–590
Song, J. and Slack, J.M.W. (1996) The cloning of Xenopus FGF-9.
Dev Dyn 206, 427–436
Suzuki, A., Yoshida, H., van Heeringen, S.J., Takebayashi-Suzuki, K.,
Veenstra, G.J.C. and Taira, M. (2017) Genomic organization and
modulation of gene expression of the TGF-beta and FGF
pathways in the allotetraploid frog Xenopus laevis. Dev. Biol. 426,
336–359
Umbhauer, M., Penzo-Me´ndez, a., Clavilier, L., Boucaut, J. and Riou,
J. (2000) Signaling specificities of fibroblast growth factor
receptors in early Xenopus embryo. J. Cell Sci. 113(Pt 1),
2865–2875
Welm, B.E., Freeman, K.W., Chen, M., Contreras, A., Spencer, D.M.
and Rosen, J.M. (2002) Inducible dimerization of FGFR1:
development of a mouse model to analyze progressive
transformation of the mammary gland. J. Cell Biol. 157, 703–714
Yamagishi, M. and Okamoto, H. (2010) Competition for ligands
between FGFR1 and FGFR4 regulates Xenopus neural
development. Int. J. Dev. Biol. 54, 93–104
Received: 18 October 2019; Revised: 31 January 2020; Accepted: 31 January 2020; Accepted article online: 6 February 2020
13C© 2020 Socie´te´ Franc¸aise des Microscopies and Socie´te´ de Biologie Cellulaire de France. Published by John Wiley & Sons Ltd
